Granules India Reports Strong Q2FY27 Results with 39% YoY PAT Growth
Granules India Ltd 路 Press Release 路 02 Nov 2026, 10:31 pm
Granules India Reports Strong Q2FY27 Results with 39% YoY PAT Growth Granules India reported Q2FY27 revenue of INR 15,600 Mn, up 20% YoY (6% QoQ), with EBITDA rising 21% YoY to INR 3,376 Mn (22% margin) and PAT surging 39% YoY to INR 1,818 Mn. Finished dosages contributed 73% of revenue, followed by API at 13%, PFI at 10%, and Peptides CDMO at 3%. Geographically, North America accounted for 72% and Europe 16%. ROCE stood at 17.6%. Aided by warrant proceeds, net cash reached INR 8,280 Mn versus net debt of INR 1,012 Mn in Q1FY27.
Original exchange filing (PDF)
More announcements from Granules India Ltd
- Schedule of Investor Meet 路 11 Nov 2026
- Change in Corporate Office Address of Registrar and Share Transfer Agent (RTA) 路 06 Nov 2026
- Transcript of the Earnings Conference Call for Q2 and the half year of FY27 路 06 Nov 2026
- Audio recording of the Earnings Conference call for Q2 and the half -year of FY27 路 03 Nov 2026
- Monitoring Agency Report for the quarter ended on September 30, 2026 路 02 Nov 2026
- Investor Presentation to Analysts/Investors 路 02 Nov 2026
- Unaudited financial results for the second quarter and half year ended on September 30,2026 路 02 Nov 2026
- Outcome of the Board meeting dated November 02, 2026. 路 02 Nov 2026
